HIV Clinical Trials Market Poised for Accelerated Growth, Forecasts Reveal Steady Expansion with Notable CAGR Through 2030
10 janv. 2024 20h48 HE
|
Research and Markets
Dublin, Jan. 10, 2024 (GLOBE NEWSWIRE) -- The "Global HIV Clinical Trials Market by Phase (Phase I, Phase II, Phase III), Study Design (Expanded Access Studies, Interventional Studies, Observational...
Outlook on the HIV Clinical Trials Global Market to 2030 - Rising Drug Approvals and New Product Launches is Driving Growth
29 août 2022 06h33 HE
|
Research and Markets
Dublin, Aug. 29, 2022 (GLOBE NEWSWIRE) -- The "Global HIV Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II, Phase III, Phase IV), by Study Design...
GeoVax Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients
24 août 2020 09h00 HE
|
GeoVax, Inc.
ATLANTA, GA, Aug. 24, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human immunotherapies and vaccines against infectious diseases...
GeoVax Provides Update on HIV Clinical Trials Program
28 nov. 2018 09h00 HE
|
GeoVax, Inc.
Innovative Combination Vaccine Advancing in Clinical Trials ATLANTA, GA, Nov. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company...